Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Telmisartan + Amlodipin, (OBG) ATC C09DB04 für die Zeit 01.03.2025 - 28.02.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Telmisartan + Amlodipin, (OBG) ATC C09DB04 für die Zeit…”. Bids close on 5 January 2027.
The work
Framework discount agreement for Telmisartan + Amlodipin (ATC C09DB04) for DAK-Gesundheit from 01.03.2025 to 28.02.2027.
- non-exclusive discount agreement
- per SGB V § 130a Abs. 8
- framework contract for multiple partners
Key facts
- Contract period
- 01.03.2025 - 28.02.2027
- Evaluation
- Not a formal procurement, but a non-exclusive framework agreement under SGB V § 130a
- Submission
- Online, on the e-procurement portal
- Price basis
- predefined discount rates
What it takes to qualify
Worth a closer look
- The document is a tender for a non-exclusive framework agreement under SGB V § 130a, not a formal public procurement under GWB, but references GWB for exclusion criteria.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Angebotsschreibenmust be submitted with the offer
- Anerkennung der vertraglichen Maßgabensigned contract with DAK terms
- Anlage 1 zum Vertragto be filled and submitted
- Anlage 2 zum VertragExcel file with drug list
- Eigenerklärung zur Nichtvorliegen von Ausschlusskriteriendeclaration of no exclusion criteria per GWB § 123, § 124